InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+95.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Torti Frank, Director. Insider active across 2 companies, notably Immunovant, Inc.. Cumulatively, 11 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €118k. Activity tracked since 10 January 2022. The latest transaction was filed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Torti Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
174,189 shares0Common StockSEC:0001764013-26-000052:0
160,035 shares@ US$27.70100.0% of flowCommon SharesSEC:0001635088-26-000036:0
1,400,000 shares@ US$3.8538.9% of flowCommon SharesSEC:0001635088-26-000019:0
175,380 shares@ US$22.4546.6% of flowCommon SharesSEC:0001140361-25-046788:0
1,836,547 shares0Common SharesSEC:0001140361-25-028453:0
199,365 shares0Common StockSEC:0001764013-25-000039:0
120,400 shares0Common StockSEC:0001764013-24-000059:0
121,916 shares0Common StockSEC:0001764013-23-000043:0
20,000 shares@ US$5.81100.0% of flowCommon StockSEC:0001764013-22-000120:0
Canonical exit: 28 Dec 2022 (T+90)
225,632 shares0Common StockSEC:0001764013-22-000089:0
100,126 shares0Common StockSEC:0001764013-22-000023:0
11 of 11 declarations
About Torti Frank
Torti Frank is Administrateur at Immunovant, Inc. and President and Vant Chair at Roivant Sciences Ltd. He has 11 filings in total, and across the 11 sampled filings, buys total 118215 EUR, sells total 0 EUR, with filings dated from 2022-01-12 to 2026-04-09. The most common transaction nature is Attribution.
